IONS logo

Ionis Pharmaceuticals (IONS) Company Overview

Profile

Full Name:

Ionis Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 17, 1991

Indexes:

Not included

Description:

Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, specializing in research and development of RNA-targeted therapy. It was founded in 1989. The product portfolio includes more than 40 potential drugs aimed at treating a wide range of therapeutic diseases. Currently, the company has three commercially approved drugs in major markets worldwide: SPINRAZA, TEGSEDI, and WAYLIVRA. There are also four drugs undergoing the company's main research: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO(a)-L Rx for cardiovascular diseases, and AKCEA-TTR-L Rx for ATTR amyloidosis treatment.

Key Details

Price

$32.90

Annual Revenue

$705.14 M(-10.48% YoY)

Annual EPS

-$3.04(-18.75% YoY)

Annual ROE

-93.10%

Beta

0.79

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Feb 19, 2025

Recent annual earnings:

Feb 19, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 11, 25 JP Morgan
Neutral
Feb 20, 25 RBC Capital
Outperform
Feb 20, 25 Needham
Buy
Feb 20, 25 Citigroup
Buy
Feb 20, 25 BMO Capital
Market Perform
Jan 15, 25 RBC Capital
Outperform
Dec 20, 24 Needham
Buy
Nov 14, 24 Piper Sandler
Overweight
Nov 7, 24 Wells Fargo
Overweight
Nov 7, 24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Ionis Pharmaceuticals?
  • Does Ionis Pharmaceuticals pay dividends?
  • What sector is Ionis Pharmaceuticals in?
  • What industry is Ionis Pharmaceuticals in?
  • What country is Ionis Pharmaceuticals based in?
  • When did Ionis Pharmaceuticals go public?
  • Is Ionis Pharmaceuticals in the S&P 500?
  • Is Ionis Pharmaceuticals in the NASDAQ 100?
  • Is Ionis Pharmaceuticals in the Dow Jones?
  • When was Ionis Pharmaceuticals's last earnings report?
  • When does Ionis Pharmaceuticals report earnings?
  • Should I buy Ionis Pharmaceuticals stock now?

What is the ticker symbol for Ionis Pharmaceuticals?

The ticker symbol for Ionis Pharmaceuticals is NASDAQ:IONS

Does Ionis Pharmaceuticals pay dividends?

No, Ionis Pharmaceuticals does not pay dividends

What sector is Ionis Pharmaceuticals in?

Ionis Pharmaceuticals is in the Healthcare sector

What industry is Ionis Pharmaceuticals in?

Ionis Pharmaceuticals is in the Biotechnology industry

What country is Ionis Pharmaceuticals based in?

Ionis Pharmaceuticals is headquartered in United States

When did Ionis Pharmaceuticals go public?

Ionis Pharmaceuticals's initial public offering (IPO) was on May 17, 1991

Is Ionis Pharmaceuticals in the S&P 500?

No, Ionis Pharmaceuticals is not included in the S&P 500 index

Is Ionis Pharmaceuticals in the NASDAQ 100?

No, Ionis Pharmaceuticals is not included in the NASDAQ 100 index

Is Ionis Pharmaceuticals in the Dow Jones?

No, Ionis Pharmaceuticals is not included in the Dow Jones index

When was Ionis Pharmaceuticals's last earnings report?

Ionis Pharmaceuticals's most recent earnings report was on Feb 19, 2025

When does Ionis Pharmaceuticals report earnings?

The next expected earnings date for Ionis Pharmaceuticals is May 7, 2025

Should I buy Ionis Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions